查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520592

2024-2032年按皮肤疾病、给药途径、配销通路及地区分類的皮肤科药物市场

Dermatological Drugs Market by Dermatological Diseases, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球皮肤科药物市场规模达238亿美元。皮肤病患病率的上升、对药妆品的需求不断增加以及个人对皮肤健康意识的不断增强是推动市场发展的一些关键因素。

皮肤科药物是用于治疗各种皮肤病的药物，包括痤疮、牛皮癣、湿疹、红斑性痤疮、皮肤癌、真菌感染以及其他影响皮肤、头髮和指甲的疾病。这些药物可以局部、口服或註射使用，这取决于所治疗的皮肤病的类型。外用皮肤科药物，包括乳膏、软膏、凝胶和喷雾剂，直接涂在皮肤上。它们最常用于治疗局部皮肤病，例如痤疮或湿疹。另一方面，全身性皮肤病药物是透过口服或註射的方式服用，并透过针对皮肤状况的根本原因发挥作用。这些药物通常用于治疗严重或广泛的皮肤病，例如牛皮癣。这些产品具有化妆品和药物特性，旨在改善皮肤的整体健康和外观。此外，皮肤科药物是由皮肤科医生或其他具有皮肤健康专业知识的医疗保健专业人员开出的，这使得全球范围内的需求不断增加。

皮肤科药物市场趋势：

该市场的主要推动力是牛皮癣、湿疹、痤疮、红斑痤疮和皮肤癌等皮肤病的日益流行。此外，越来越多的老年人口更容易患此类疾病，这是另一个主要的生长诱导因素。除此之外，人们广泛采用药妆品，它们是具有药物特性的化妆品，可改善皮肤的整体健康和外观。再加上人们对维持皮肤健康重要性的认识不断增强，正在对市场成长产生正面影响。现在，患者更加意识到寻求皮肤病治疗，导致皮肤科药物的整体需求增加。此外，药物传递系统的各种技术进步，如透皮贴片、奈米技术和微针，正在推动皮肤科药物市场的成长。这些新的药物输送系统提高了药物的功效并提高了患者的依从性。此外，消费者可支配收入的增加、非处方药（OTC）的日益普及以及对可用治疗方案的认识不断提高是在全球范围内创造良好市场前景的其他一些因素。

本报告回答的关键问题：

  • 迄今为止，全球皮肤科药物市场表现如何，未来几年将如何表现？
  • 全球皮肤科药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球皮肤科药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的皮肤科药物市场？
  • 基于皮肤病的市场区隔是什么？
  • 皮肤科用药市场上最吸引人的皮肤科疾病是什么？
  • 根据给药途径，市场的分化为何？
  • 皮肤科药物市场上哪种给药途径最具吸引力？
  • 基于配销通路的市场区隔是什么？
  • 皮肤科药品市场最具吸引力的配销通路是哪一个？
  • 全球皮肤科用药市场竞争格局如何？
  • 全球皮肤科药物市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球皮肤科药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：依皮肤病分类

  • 粉刺
    • 市场走向
    • 市场预测
  • 皮肤炎
    • 市场走向
    • 市场预测
  • 牛皮癣
    • 市场走向
    • 市场预测
  • 皮肤癌
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依管理途径

  • 口服
    • 市场走向
    • 市场预测
  • 注射用
    • 市场走向
    • 市场预测
  • 专题
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AbbVie Inc.
    • Amgen Inc.
    • Bausch Health Companies Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • GSK plc
    • LEO Pharma A/S (LEO Holding A/S)
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112024A7758

The global dermatological drugs market size reached US$ 23.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 53.3 Billion by 2032, exhibiting a growth rate (CAGR) of 9.1% during 2024-2032. The rising prevalence of skin disorders, the increasing demand for cosmeceuticals, and the growing awareness among individuals about skin health represent some of the key factors driving the market.

Dermatological drugs are medications that are used to treat various skin conditions, including acne, psoriasis, eczema, rosacea, skin cancer, fungal infections, and other disorders affecting the skin, hair, and nails. These drugs can be applied topically, orally, or by injection, depending on the type of skin condition being treated. Topical dermatological drugs, including creams, ointments, gels, and sprays, are directly applied to the skin. They are most commonly used to treat localized skin conditions, such as acne or eczema. On the other hand, systemic dermatological drugs are taken orally or by injection and work by targeting the underlying cause of a skin condition. These drugs are often used to treat severe or widespread skin conditions, such as psoriasis. These products have both cosmetic and pharmaceutical properties, and they are designed to improve the overall health and appearance of the skin. Moreover, dermatological drugs are prescribed by dermatologists or other healthcare professionals with expertise in skin health, which is escalating their demand across the globe.

Dermatological Drugs Market Trends:

The market is primarily driven by the increasing prevalence of skin disorders such as psoriasis, eczema, acne, rosacea, and skin cancer. In addition, the rising geriatric population that is more susceptible to such ailments represents another major growth-inducing factor. Besides this, individuals are widely adopting cosmeceuticals, which are cosmetic products with pharmaceutical properties to improve the overall health and appearance of the skin. This, coupled with the growing awareness among individuals about the importance of maintaining healthy skin, is positively influencing the market growth. Patients are now more aware of seeking treatment for skin conditions, leading to an increase in the overall demand for dermatological drugs. Moreover, various technological advancements in drug delivery systems, such as transdermal patches, nanotechnology, and microneedles, are driving the growth of the dermatological drugs market. These new drug delivery systems improve the efficacy of drugs and enhance patient compliance. Furthermore, the rising disposable incomes of consumers, the growing popularity of over the counter (OTC) drugs and the increasing awareness regarding the available treatment options are some of the other factors creating a favorable market outlook across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global dermatological drugs market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on dermatological diseases, route of administration, and distribution channel.

Dermatological Diseases Insights:

Dermatological Drugs Market

Acne

Dermatitis

Psoriasis

Skin Cancer

Others

The report has provided a detailed breakup and analysis of the dermatological drugs market based on the dermatological diseases. This includes acne, dermatitis, psoriasis, skin cancer, and others. According to the report, psoriasis represented the largest segment.

Route of Administration Insights:

Oral

Parenteral

Topical

A detailed breakup and analysis of the dermatological drugs market based on the route of administration has also been provided in the report. This includes oral, parenteral, and topical. According to the report, parenteral accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has provided a detailed breakup and analysis of the dermatological drugs market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for dermatological drugs. Some of the factors driving the North America dermatological drugs market included the growing prevalence of skin conditions, the rising awareness regarding appearance, and the escalating demand for cosmeceuticals.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global dermatological drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Amgen Inc., Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GSK plc, LEO Pharma A/S (LEO Holding A/S), Novartis AG, Pfizer Inc., Sanofi S.A., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global dermatological drugs market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global dermatological drugs market?
  • What is the impact of each driver, restraint, and opportunity on the global dermatological drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive dermatological drugs market?
  • What is the breakup of the market based on dermatological diseases?
  • Which is the most attractive dermatological disease in the dermatological drugs market?
  • What is the breakup of the market based on the route of administration?
  • Which is the most attractive route of administration in the dermatological drugs market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the dermatological drugs market?
  • What is the competitive structure of the global dermatological drugs market?
  • Who are the key players/companies in the global dermatological drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dermatological Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dermatological Diseases

  • 6.1 Acne
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Dermatitis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Psoriasis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Skin Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bausch Health Companies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 LEO Pharma A/S (LEO Holding A/S)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pfizer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Dermatological Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Dermatological Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Dermatological Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Dermatological Drugs Market: Breakup by Dermatological Diseases (in %), 2023
  • Figure 5: Global: Dermatological Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Dermatological Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Dermatological Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Dermatological Drugs (Acne) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Dermatological Drugs (Acne) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Dermatological Drugs (Dermatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Dermatological Drugs (Dermatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Dermatological Drugs (Psoriasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Dermatological Drugs (Psoriasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Dermatological Drugs (Skin Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Dermatological Drugs (Skin Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Dermatological Drugs (Other Dermatological Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Dermatological Drugs (Other Dermatological Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Dermatological Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Dermatological Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Dermatological Drugs (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Dermatological Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Dermatological Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Dermatological Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Dermatological Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Dermatological Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Dermatological Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Dermatological Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Dermatological Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Dermatological Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Dermatological Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Dermatological Drugs Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Dermatological Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Dermatological Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 80: Global: Dermatological Drugs Industry: Value Chain Analysis
  • Figure 81: Global: Dermatological Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dermatological Drugs Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Dermatological Drugs Market Forecast: Breakup by Dermatological Diseases (in Million US$), 2024-2032
  • Table 3: Global: Dermatological Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Dermatological Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Dermatological Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Dermatological Drugs Market: Competitive Structure
  • Table 7: Global: Dermatological Drugs Market: Key Players